These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 26656238)

  • 1. Regulatory Forum Opinion Piece*: An Experienced Pathologist Need Not Always Be Present at Necropsy for Small Molecule or Biotherapeutic Safety Studies.
    Nikula KJ
    Toxicol Pathol; 2016 Jan; 44(1):12-3. PubMed ID: 26656238
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulatory Forum Opinion Piece*: An Experienced Pathologist Should Be Present at Necropsy for Novel Medical Device Studies.
    Nikula KJ; Funk K
    Toxicol Pathol; 2016 Jan; 44(1):9-11. PubMed ID: 26656240
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulatory forum opinion piece: Clarification and simplification of the pathology peer review documentation process.
    Tomlinson MJ; Leininger JR
    Toxicol Pathol; 2014; 42(2):309-10. PubMed ID: 24357643
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulatory Forum Opinion Piece*: Dispelling Confusing Pathology Terminology: Recognition and Interpretation of Selected Rodent Renal Tubule Lesions.
    Seely JC; Frazier KS
    Toxicol Pathol; 2015 Jun; 43(4):457-63. PubMed ID: 25869578
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulatory forum opinion piece: Peer review documentation and pathology data locking.
    Neef N
    Toxicol Pathol; 2014; 42(2):311-3. PubMed ID: 24357644
    [No Abstract]   [Full Text] [Related]  

  • 6. The role of the pathologist in GLP studies.
    Weber K; Hailey JR; Mann PC; Seaton M; Funk KA
    Toxicol Pathol; 2014 Jan; 42(1):275. PubMed ID: 24436040
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of the study pathologist.
    Weber K
    Toxicol Pathol; 2014 Jan; 42(1):276-7. PubMed ID: 24334675
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulatory forum opinion piece: differences between protein-based biologic products (biotherapeutics) and chemical entities (small molecules) of relevance to the toxicologic pathologist.
    Leach MW
    Toxicol Pathol; 2013 Jan; 41(1):128-36. PubMed ID: 22744226
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulatory forum opinon piece: raw data in pathology--always a conundrum, often a controversy.
    Kerlin RL
    Toxicol Pathol; 2012 Jun; 40(4):695-6. PubMed ID: 22593233
    [No Abstract]   [Full Text] [Related]  

  • 10. Recommendations for pathology peer review.
    Morton D; Sellers RS; Barale-Thomas E; Bolon B; George C; Hardisty JF; Irizarry A; McKay JS; Odin M; Teranishi M
    Toxicol Pathol; 2010 Dec; 38(7):1118-27. PubMed ID: 20924082
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulatory forum opinion piece*: tissue cross-reactivity studies: what constitutes an adequate positive control and how do we report positive staining?
    Geoly FJ
    Toxicol Pathol; 2014 Aug; 42(6):954-6. PubMed ID: 23847038
    [No Abstract]   [Full Text] [Related]  

  • 12. High-risk molecules or insufficient scientific data?
    Mignot A
    Clin Pharmacol Ther; 2008 Feb; 83(2):365-7. PubMed ID: 18091760
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulatory forum opinion piece: the role of the toxicologic pathologist in the postgenomic era: challenges and opportunities.
    Maronpot RR
    Toxicol Pathol; 2012 Oct; 40(7):1082-6. PubMed ID: 22585943
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Is Science the Only Driver in Species Selection? An Internal Study to Evaluate Compound Requirements in the Minipig Compared to the Dog in Preclinical Studies.
    Schaefer K; Rensing S; Hillen H; Burkhardt JE; Germann PG
    Toxicol Pathol; 2016 Apr; 44(3):474-9. PubMed ID: 26839331
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pathology working groups.
    Mann PC; Hardisty JH
    Toxicol Pathol; 2014 Jan; 42(1):283-4. PubMed ID: 24190914
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Scientific and Regulatory Policy Committee Points-to-consider Paper*: Drug-induced Vascular Injury Associated with Nonsmall Molecule Therapeutics in Preclinical Development: Part I. Biotherapeutics.
    Frazier KS; Engelhardt JA; Fant P; Guionaud S; Henry SP; Leach MW; Louden C; Scicchitano MS; Weaver JL; Zabka TS;
    Toxicol Pathol; 2015 Oct; 43(7):915-34. PubMed ID: 25722122
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulatory forum opinion piece: what are pathology raw data?
    Leininger JR; Parker GA
    Toxicol Pathol; 2014; 42(3):469-71. PubMed ID: 23960165
    [No Abstract]   [Full Text] [Related]  

  • 18. Regulatory forum opinion piece: blind reading of histopathology slides in general toxicology studies.
    Neef N; Nikula KJ; Francke-Carroll S; Boone L
    Toxicol Pathol; 2012 Jun; 40(4):697-9. PubMed ID: 22407309
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulatory forum opinion piece: thresholds in toxicologic pathology.
    Long GG; Hardisty JF
    Toxicol Pathol; 2012 Oct; 40(7):1079-81. PubMed ID: 22585940
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The study pathologist's role in GLP studies: a regulator's perspective.
    Seaton M
    Toxicol Pathol; 2014 Jan; 42(1):285. PubMed ID: 24178580
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.